Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

CA16020733

805828 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 05f21f32-b0f9-4eca-84f5-fd9d2bfd7711

Approved on: 2019-04-09

Published on: 2019-04-09

HGVS expressions

NM_001354304.1:c.168+2T>C

NM_000277.1:c.168+2T>C

NM_000277.2:c.168+2T>C

NM_000277.3:c.168+2T>C

NM_001354304.2:c.168+2T>C

ENST00000307000.7:c.153+2T>C

ENST00000546844.1:c.168+2T>C

ENST00000548677.2:n.255+2T>C

ENST00000548928.1:n.90+2T>C

ENST00000549111.5:n.264+2T>C

ENST00000550978.6:n.152+2T>C

ENST00000551337.5:c.168+2T>C

ENST00000551988.5:n.257+2T>C

ENST00000553106.5:c.168+2T>C

ENST00000635500.1:n.136+2T>C

NC_000012.12:g.102912789A>G

CM000674.2:g.102912789A>G

NC_000012.11:g.103306567A>G

CM000674.1:g.103306567A>G

NC_000012.10:g.101830697A>G

NG_008690.1:g.9814T>C

NG_008690.2:g.50622T>C

Pathogenic

PM3 PP4_Moderate PM2 PVS1_Strong

Evidence Links 1

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.168+2T>C variant in PAH was reported in one patient with PKU (BH4 deficiency excluded) in trans with p.R243Q (PP4_Moderate, PM3; PMID: 28982351). This variant is absent from population databases, including gnomAD (PM2). This variant occurs at a canonical splice site, which will result in abnormal splicing at the donor site of intron 2 where LOF is a known mechanism of disease, exon skipping preserves reading frame, but the altered region is critical to protein function (14 non-truncating pathogenic variants in the region). (PVS1_strong). In summary, this variant meets the criteria to be classified pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PVS1_strong, PM2, PM3.

PM3

detected in trans with p.R243Q (P, 7 submitters)

Variant detected in one patient with a pathogenic missense (p.R243Q) in trans. PubMed:28982351

PP4_Moderate

detected in one patient with PKU. BH4 cofactor deficiency was ruled out. Phenylalanine pre treatment was > 120 uM. PMID: 28982351

Variant detected in a cohort of phenylketonuria in one patient with a pathogenic missense (p.R243Q) in trans. BH4 cofactor deficiency was ruled out. Phenylalanine pre treatment was > 120 uM. PubMed:28982351

PM2

No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline

PVS1_Strong

Null variant (canonical +/- 1 or 2 splice sites) where LOF is a known mechanism of disease, exon skipping preserves reading frame, but the altered region is critical to protein function (14 non-truncating pathogenic variants in the region).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.